Clinical Trials

Status
Published

Recently Activated

SHOW MORE
Open
Phase
III
Accrual
0%
SWOG Clinical Trial Number
S1806
Open
SWOG Clinical Trial Number
CTSU/NRG-BR004

A Randomized, Double-Blind, Phase III Trial of Paclitaxel/ Trastuzumab/ Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Status Notes
Activated by NRG: 3/12/19.
Activated by SWOG: 4/1/19.
Activated
04-01-2019
ClinicalTrials.gov Registry Number
NCT03199885
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
S1714

A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients

Status Notes
This study is active as of 3/1/19.
Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Lung Cancer
Early Therapeutics & Rare Cancers
Activated
03-01-2019
Open
Phase
SWOG Clinical Trial Number
CTSU/EAE161

Perfusion CT to Predict Progression-free Survival and Response Rate in Bevacizumab and Paclitaxel Treatment of Platinum-Resistant Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma

Status Notes
SWOG Activated/Championed CTSU/EAE161, effective March 1, 2019
Research Committee(s)
Early Therapeutics & Rare Cancers
Activated
03-01-2019
ClinicalTrials.gov Registry Number
NCT03412630
Open
Phase
III
Accrual
2%
SWOG Clinical Trial Number
S1600

A Randomized Phase III Double-Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes

Status Notes
This study is open effective February 21, 2019 at 2:00 p.m. Eastern.
Research Committee(s)
Symptom Control and Quality of Life
Genitourinary Cancer
Activated
02-21-2019
ClinicalTrials.gov Registry Number
NCT03757949